SCHEMBL13899486

SCHEMBL13899486

COC(=O)Cc1nn(-c2ccccc2)nc1C

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.55
PKM P14618 3/20 0.55
KDM4E B2RXH2 4/20 0.53
TSHR P16473 3/20 0.52
CYP3A4 P08684 1/20 0.52
ADORA3 P0DMS8 1/20 0.50
ADORA2A P29274 1/20 0.50
ADORA2B P29275 1/20 0.50
ADORA1 P30542 1/20 0.50
KAT2B Q92831 1/20 0.50
MAPT P10636 1/20 0.48
ALDH1A1 P00352 2/20 0.47
GAA P10253 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
HDAC1 Q13547 1/20 0.43
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13899493 0.86 TSHR (0.59) LMNAPKMKDM4ETSHRCYP3A4
SCHEMBL5324874 0.84 LMNA (0.55) LMNAPKMKDM4ETSHRCYP3A4
SCHEMBL14188814 0.82 MAPT (0.48) LMNAPKMKDM4ETSHRCYP3A4
SCHEMBL5327176 0.82 LMNA (0.47) LMNAPKMKDM4ETSHRCYP3A4
SCHEMBL201295 0.79 LMNA (0.51) LMNAPKMKDM4ETSHRCYP3A4
SCHEMBL29255201 0.78 PKM (0.39) LMNAPKMKDM4ETSHRCYP3A4
SCHEMBL29254867 0.78 LMNA (0.46) LMNAPKMTSHRCYP3A4MAPT
SCHEMBL24701303 0.76 CYP3A4 (0.48) LMNAPKMKDM4ETSHRCYP3A4
SCHEMBL12509518 0.74 KDM4E (0.47) LMNAPKMKDM4ETSHRCYP3A4
SCHEMBL13899484 0.74 LMNA (0.48) LMNAPKMKDM4ETSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7507757-B2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method BRISTOL-MYERS SQUIBB COMPANY (US) 2009-03-24 US disclosed